Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MARK3 | P27448 | 2/20 | 0.33 |
| ▸ | MARK4 | Q96L34 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22177124 | 0.82 | MARK3 (0.34) | MARK3MARK4MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL25849711 | 0.81 | MAPT (0.41) | MAPTKMT2ASMN1; SMN2MEN1NPC1 | |
| SCHEMBL22177566 | 0.81 | OPRM1 (0.42) | OPRL1OPRM1OPRK1 | |
| SCHEMBL22177496 | 0.81 | MARK3 (0.33) | MARK3MARK4MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL24592723 | 0.80 | KMT2A (0.34) | MAPTKMT2ASMN1; SMN2MEN1NPC1 | |
| SCHEMBL22177757 | 0.79 | PGR (0.36) | MAPTKMT2ASMN1; SMN2MEN1NPC1 | |
| SCHEMBL22178282 | 0.79 | ALDH1A1 (0.38) | MAPTKMT2ASMN1; SMN2MEN1NPC1 | |
| SCHEMBL17773906 | 0.74 | MAPT (0.32) | MAPTKMT2ASMN1; SMN2MEN1NPC1 | |
| SCHEMBL22178287 | 0.74 | PGR (0.34) | MARK3MARK4MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL25849792 | 0.74 | MAPT (0.46) | MAPTKMT2ASMN1; SMN2MEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11785843-B2 | Photoelectric conversion element, optical sensor, and imaging element | FUJIFILM CORPORATION (JP) | 2023-10-10 | — | — | US | disclosed |
| US-11785843-B2 | Photoelectric conversion element, optical sensor, and imaging element | FUJIFILM CORPORATION (JP) | 2023-10-10 | — | — | US | disclosed |
| US-20200212107-A1 | PHOTOELECTRIC CONVERSION ELEMENT, OPTICAL SENSOR, AND IMAGING ELEMENT | FUJIFILM CORPORATION (JP) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11785843-B2 | Photoelectric conversion element, optical sensor, and imaging element | CRY1, PIN4, PPOX | MARK3 640/4885MARK4 342/4885MAPT 702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.